Where is nano today and where is it headed? A review of nanomedicine and the dilemma of nanotoxicology
C Domingues, A Santos, C Alvarez-Lorenzo… - ACS …, 2022 - ACS Publications
Worldwide nanotechnology development and application have fueled many scientific
advances, but technophilic expectations and technophobic demands must be …
advances, but technophilic expectations and technophobic demands must be …
[HTML][HTML] Exosome nanovesicles: a potential carrier for therapeutic delivery
Exosomes are small nanosized biovesicles that form when multivesicular bodies and the
plasma membrane fuse and are released into the surrounding body fluids. They are best …
plasma membrane fuse and are released into the surrounding body fluids. They are best …
Aptamer–Protein Interactions: From Regulation to Biomolecular Detection
C Ji, J Wei, L Zhang, X Hou, J Tan, Q Yuan… - Chemical …, 2023 - ACS Publications
Serving as the basis of cell life, interactions between nucleic acids and proteins play
essential roles in fundamental cellular processes. Aptamers are unique single-stranded …
essential roles in fundamental cellular processes. Aptamers are unique single-stranded …
Apigenin in cancer prevention and therapy: A systematic review and meta-analysis of animal models
Background Apigenin is being increasingly recognized as a cancer chemopreventive agent.
We aimed to investigate the anticancer effects of Apigenin in in-vivo studies to know its …
We aimed to investigate the anticancer effects of Apigenin in in-vivo studies to know its …
Nanotherapeutic treatment of the invasive glioblastoma tumor microenvironment
N Pandey, P Anastasiadis, CP Carney… - Advanced Drug Delivery …, 2022 - Elsevier
Glioblastoma (GBM) is the most common malignant adult brain cancer with no curative
treatment strategy. A significant hurdle in GBM treatment is effective therapeutic delivery to …
treatment strategy. A significant hurdle in GBM treatment is effective therapeutic delivery to …
siRNA‐based nanotherapeutics as emerging modalities for immune‐mediated diseases: A preliminary review
Immune‐mediated diseases (IMDs) are chronic conditions that have an immune‐mediated
etiology. Clinically, these diseases appear to be unrelated, but pathogenic pathways have …
etiology. Clinically, these diseases appear to be unrelated, but pathogenic pathways have …
[HTML][HTML] Inorganic nanoparticles in bone healing applications
Modern biomedicine aims to develop integrated solutions that use medical,
biotechnological, materials science, and engineering concepts to create functional …
biotechnological, materials science, and engineering concepts to create functional …
[HTML][HTML] CD133-functionalized gold nanoparticles as a carrier platform for telaglenastat (CB-839) against tumor stem cells
E Poonaki, AC Nickel, M Shafiee Ardestani… - International journal of …, 2022 - mdpi.com
The failure of a long-lasting curative therapeutic benefit of currently applied chemotherapies
against malignant cancers is suggested to be caused by the ineffectiveness of such …
against malignant cancers is suggested to be caused by the ineffectiveness of such …
[HTML][HTML] Accentuating CircRNA-miRNA-transcription factors axis: a conundrum in cancer research
D Singh, P Kesharwani, NA Alhakamy… - Frontiers in …, 2022 - frontiersin.org
Circular RNAs (circRNAs) are the newly uncovered class of non-coding RNAs being
cognized as profound regulators of gene expression in developmental and disease biology …
cognized as profound regulators of gene expression in developmental and disease biology …
Protective effect of green synthesized Selenium Nanoparticles against Doxorubicin induced multiple adverse effects in Swiss albino mice
Aims Doxorubicin (DOX) is a widely used drug against multiple cancers. However, its clinical
Use is often restricted due to multiple adverse effects. Recently, Selenium Nanoparticles …
Use is often restricted due to multiple adverse effects. Recently, Selenium Nanoparticles …